Figure 3.
Effects of PTX incubation of hematopoietic progenitor cells on homing. Lethally irradiated hosts received transplants of BM or FL cells, and nonirradiated hosts received transplants of BM cells from neo-resistant donors. Transplants incubated in SCF for 20 hours in the absence or presence of PTX were injected into the hosts. After 24 hours, recovery of CFU-Cs (neo-resistant CFU-Cs in the nonirradiated hosts) from BM, peripheral blood, and spleen was assessed in colony assays. Numbers are given as the percentage of injected CFU-Cs per femur (mean ± SEM), per milliliter blood, and per spleen. ▦ indicates control cells; and ▪, PTX-treated cells. **P < .005. *P < .01 compared with control. (A) Homing of PTX-treated adult BM CFU-Cs to BM was reduced more than 75%. Concomitantly, circulating CFU-Cs were several-fold increased in recipients of PTX-treated cells. (B) BM homing of PTX-treated day-15 FL CFU-Cs also was reduced by more than 75%, with a similar increase of circulating CFU-Cs. (C) In nonirradiated hosts, BM homing of PTX-treated BM CFU-Cs was similarly reduced as in irradiated hosts, and circulating CFU-Cs were similarly increased. In contrast to the irradiated spleens, nonirradiated spleens also showed greatly attenuated homing (> 75% decrease) of PTX-treated donor CFU-Cs from adult BM.